Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AIM
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 35,000 | $0.149 | $5,215 Buy | Form 4 ↗ |
| Nov 10, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 39,000 | $0.138 | $5,382 Buy | Form 4 ↗ |
| Nov 9, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 31,298 | $0.162 | $5,070 Buy | Form 4 ↗ |
| Nov 6, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 12,751 | $0.158 | $2,015 Buy | Form 4 ↗ |
| Nov 6, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 20,299 | $0.156 | $3,167 Buy | Form 4 ↗ |
| Oct 23, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 31,675 | $0.16 | $5,068 Buy | Form 4 ↗ |
| Oct 22, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 31,250 | $0.163 | $5,094 Buy | Form 4 ↗ |
| Sep 17, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 24,000 | $0.21 | $5,040 Buy | Form 4 ↗ |
| Sep 16, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 11,000 | $0.21 | $2,310 Buy | Form 4 ↗ |
| Sep 15, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 22,000 | $0.22 | $4,840 Buy | Form 4 ↗ |
| Sep 14, 2026 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 5,900 | $0.22 | $1,298 Buy | Form 4 ↗ |
| Jun 13, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 107 | $7.70 | $824 Buy | Form 4 ↗ |
| Jun 12, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 103 | $8.70 | $896 Buy | Form 4 ↗ |
| Apr 11, 2025 | William M. Mitchell Director | AIM AIM ImmunoTech Inc. | Buy | 196,851 | $0.03 | $5,906 Buy | Form 4 ↗ |
| Apr 11, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 1.97M | $0.03 | $59.1K Buy | Form 4 ↗ |
| Apr 11, 2025 | Ted D. Kellner Director | AIM AIM ImmunoTech Inc. | Buy | 1.97M | $0.03 | $59.1K Buy | Form 4 ↗ |
| Apr 4, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 41,000 | $0.06 | $2,460 Buy | Form 4 ↗ |
| Apr 4, 2025 | Peter W. Rodino III COO, Secretary, Gen. Counsel | AIM AIM ImmunoTech Inc. | Buy | 500 | $0.09 | $45 Buy | Form 4 ↗ |
| Mar 5, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 50,000 | $0.13 | $6,500 Buy | Form 4 ↗ |
| Mar 4, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 44,000 | $0.12 | $5,280 Buy | Form 4 ↗ |
| Mar 4, 2025 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 83,334 | $0.12 | $10.0K Buy | Form 4 ↗ |
| Dec 19, 2024 | William M. Mitchell Director | AIM AIM ImmunoTech Inc. | Sale | 4,580 | $0.19 | $870 Sale | Form 4 ↗ |
| Dec 18, 2024 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 22,727 | $0.21 | $4,773 Buy | Form 4 ↗ |
| Dec 2, 2024 | Stewart Appelrouth Director | AIM AIM ImmunoTech Inc. | Buy | 11,111 | $0.21 | $2,333 Buy | Form 4 ↗ |
| Dec 2, 2024 | Stewart Appelrouth Director | AIM AIM ImmunoTech Inc. | Buy | 1 | $0.21 | $0.21 Buy | Form 4 ↗ |
| Nov 21, 2024 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 20,000 | $0.21 | $4,200 Buy | Form 4 ↗ |
| Nov 20, 2024 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 85,000 | $0.20 | $17.0K Buy | Form 4 ↗ |
| Nov 20, 2024 | Stewart Appelrouth Director | AIM AIM ImmunoTech Inc. | Buy | 81,953 | $0.19 | $15.6K Buy | Form 4 ↗ |
| Nov 20, 2024 | Thomas K. Equels CEO & President, Director | AIM AIM ImmunoTech Inc. | Buy | 60,110 | $0.18 | $10.8K Buy | Form 4 ↗ |
29 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:58 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances